Topics

According to the FDA:  

Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living cells for therapeutic use.

Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms:

  • Replacing a disease-causing gene with a healthy copy of the gene
  • Inactivating a disease-causing gene that is not functioning properly
  • Introducing a new or modified gene into the body to help treat a disease

Gene therapy products are being studied to treat diseases including cancer, genetic diseases, and infectious diseases.

There are a variety of types of gene therapy products, including:

  • Plasmid DNA: Circular DNA molecules can be genetically engineered to carry therapeutic genes into human cells.
  • Viral vectors: Viruses have a natural ability to deliver genetic material into cells, and therefore some gene therapy products are derived from viruses. Once viruses have been modified to remove their ability to cause infectious disease, these modified viruses can be used as vectors (vehicles) to carry therapeutic genes into human cells.
  • Bacterial vectors: Bacteria can be modified to prevent them from causing infectious disease and then used as vectors (vehicles) to carry therapeutic genes into human tissues.
  • Human gene editing technology: The goals of gene editing are to disrupt harmful genes or to repair mutated genes.
  • Patient-derived cellular gene therapy products: Cells are removed from the patient, genetically modified (often using a viral vector) and then returned to the patient.

Source:  https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy 

medical treatments
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
Affidavit of LTC. Theresa Long M.D. in Support of a Motion for a Preliminary Injunction Order
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
CDC REMOVES Their Claim That mRNA & Spike Protein "Do Not Last Long In The Body”
Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis
Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 Vaccine: Critical Questions with Complicated Answers
Expert testimony of Dr. Christina Parks, PhD
Fauci on Antibody Dependent Enhancement (ADE)
Florida State Surgeon General Calls for Halt in the Use of COVID-19 mRNA Vaccines
mRNA Platform: Enabling Drug Discovery & Development
mRNA, Nanolipid Particles and PEG: A Triad Never Used in Clinical Vaccines is Going to Be Tested on Hundreds of Millions of People
mRNA: Vaccine or Gene Therapy? The Safety Regulatory Issues
Press Release: UK Doctors Call For Government To Urgently Pause and Investigate the Use of Novel mRNA Covid Vaccines
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
Statement by Dr. Dean Patterson
What is Gene Therapy?
1439